Medtronic plc (MDT)
NYSE: MDT · Electromedical & Electrotherapeutic Apparatus · Galway · filing with the SEC since 2014
Grade6.3
◀ Past 7.1● Present 6.6▶ Future 5.1
Who owns Medtronic plc
As filed with the SECHolders of 5% or more
2
Vanguard Capital Management holds 7.51% of Common Stock, as its SCHEDULE 13G filed Apr 28, 2026 says.
Directors and officers
21
report now, of 45 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 28, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 10.2% in Dec 3, 2025
What MDT reports owning in othersstakes of 5% or more, and other ties
Orchestra BioMed Holdings, Inc. OBIO
SCHEDULE 13G/A · filed Feb 27, 2026 · Common Stock, Par Value $0.0001 Per Share
Anteris Technologies Global Corp. AVR
SCHEDULE 13D · filed Jan 29, 2026 · Common Stock
MiniMed Group, Inc. MMED
SCHEDULE 13G/A · filed Oct 16, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%
Other ties the annual report names
MiniMed Group, Inc.
An entity · legal entity · owns, named in the 10-K filed Jun 18, 2026
CathWorks Ltd
A company bought · acquisition · owns, named in the 10-K filed Jun 18, 2026
365 subsidiaries in 70 countries, from the list filed with the 10-K filed Jun 18, 2026.
Insider tradesForm 4
18sales
0purchases
3sales on a scheduled plan
5people selling
$14.7Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 46 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kiil Harry Skip | EVP & President Cardiovascular | 8 | $5.6M | 0 | 0 | $0 |
| Martha Geoffrey | Chairman and CEO | 1 | $4.8M | 1 | 0 | $0 |
| Smith Gregory L | EVP Global Ops & Supply Chain | 7 | $3.1M | 0 | 0 | $0 |
| Marinaro Michael | President | 1 | $1.0M | 1 | 0 | $0 |
| Walter Matthew R. | SVP, Chief HR Officer | 1 | $300,000 | 1 | 0 | $0 |